Fleming, John et al "Clinical Trial of Helminth-induced Immunomodulatory Therapy (HINT 2) in Relapsing-Remitting Multiple Sclerosis (P3.149)." Neurology 82.10 Supplement (2014): P3.149. Web. 29 June. 2022.